Summary
Pharmacokinetics of Astragaloside IV (AGS-IV) in rats was studied by high performance liquid chromatography coupled with tandem mass spectrometry. The concentration in plasma was determined after iv administration of 1, 2, 4mg/kg and po administration of 20mg/kg of AGS-IV. The AUC were linearly correlated to doses. Recoveries of AGS-IV in bile, urine and feces were also analyzed following iv dose of 2 mg/kg. Cumulative recovery of AGS-IV in bile reached 30.8% in 24h. Cumulative recovery of AGS-IV in urine and feces was 52.14%, which indicates that about 50% of AGS-IV was metabolized in vivo. The bioavailability of AGS-IV after po administration was found to be 3.66%. These findings provide useful information for the research and development of AGS-IV and other potential agents.
Similar content being viewed by others
References
Pharmacopoeia of PR China (English Edition 2000) vol. I, The State Pharmacopoeia Commission, C hemical Industry Press, Beijing, China, 2000, 161.
Luo Y, Qin Z, Hong Z, et al (2004): Astragaloside IV protects against ischemic brain injury in a murine model of transient focal ischemia. Neurosci Lett, 363, 218–23.
Wang YP, Li XY, Song CQ, et al(2002): Effect of astragaloside IV on T, B lymphocyte proliferation and peritoneal macrophage function in mice. Acta Pharmacol Sin 23, 263–266.
Yao MC, Qi Y, Bi KS, et al (2000): A precolumn derivatization high performance liquid chromatographic method with improved sensitivity and specificity for the determination of astragaloside Δτ in radix astragali. J Chromatogr Sei, 38(8), 325–328
Determination of astragaloside Δτ in Radix astragali (Astragalus membranaceusvar. monghulicus) using high performance liquid chromatography with evaporative light scattering detection. J Chromatogr Sei, 39(11), 459-462
Gu, YC, G J Wang, J. P Fawcett (2004): Determination of Astragaloside IV in rat plasma by liquid chromatography-electrospray ionization mass spectrometry. J Chromatogr B, 801, 285–288
Zhang WD, Zhang C, Liu RH, et al (2005): Quantitative determination of Astragaloside IV, a natural product with cardioprotective activity, in plasma, urine and other biological samples by HPLC coupled with tandem mass spectrometry. J Chromatogr B, 822, 170–177
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Du, Y., Zhang, Q., Chen, G. et al. Pharmacokinetics of Astragaloside IV in rats by liquid chromatography coupled with tandem mass spectrometry. European Journal of Drug Metabolism and Pharmacokinetics 30, 269–273 (2005). https://doi.org/10.1007/BF03190631
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF03190631